TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT02401269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02401269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT00595894 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04515147 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT04482764 — Pharmacodynamic Biomarker (PDY): Valproic acid
Study NCT04090528 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study NCT04090528 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02064881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT02064881 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT03372733 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00837148 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT02906670 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02906670 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02906670 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT02976857 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03566030 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02843048 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT00470470 — Predictive Biomarker (PRD): KIT mRNA
Genes: KIT; SCFR
Study NCT00450593 — Predictive Biomarker (PRD): CDKN2A mRNA
Genes: CDKN2A; CDKN2; MTS1
Study NCT04670328 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04670328 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04371289 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT04173507 — Safety Biomarker (SAF): Serine/threonine-protein kinase STK11
Genes: STK11
Study NCT04091516 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04089579 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT01983579 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT01983579 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT03888612 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT02586974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02586974 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02433132 — Predictive Biomarker (PRD): CFTR mRNA
Genes: CFTR; ABCC7
Study NCT02433132 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT03102606 — Surrogate Endpoint (SUR): Duration of severe neutropenia
Study NCT03102606 — Safety Biomarker (SAF): Neutrophil to lymphocyte
Study NCT04066452 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT01522911 — Safety Biomarker (SAF): Natriuretic peptides A
Genes: NPPA; ANP; PND
Study NCT03821233 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02500095 — Predictive Biomarker (PRD): Hormone receptor
Study NCT02465905 — Monitoring Biomarker (MOI): IL4 mRNA
Genes: IL4
Study NCT02465905 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study NCT02465905 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study NCT02152137 — Predictive Biomarker (PRD): PPARA mRNA
Genes: PPARA; NR1C1; PPAR
Study NCT00194441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01735461 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT04517305 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT02930499 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT00711087 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT01334229 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT04881474 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04378972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04378972 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT04411147 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00114140 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT01368497 — Monitoring Biomarker (MOI): HBV DNA
Study NCT02816736 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study NCT03791112 — Predictive Biomarker (PRD): BPI mRNA
Genes: BPI
Study NCT04429542 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04293874 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00655993 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01176006 — Predictive Biomarker (PRD): DOCK8 mRNA
Genes: DOCK8
Study NCT00926952 — Predictive Biomarker (PRD): MAL mRNA
Genes: MAL
Study NCT02302417 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT00922441 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02031861 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01518322 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study NCT04062669 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00659711 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT00075816 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00075816 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02005289 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT02845713 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT03922321 — Predictive Biomarker (PRD): TSHR mRNA
Genes: TSHR; LGR3
Study NCT00155311 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT02522689 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study NCT01511042 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Angiotensinogen
Genes: AGT; SERPINA8
Study NCT01511042 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00396682 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT01472692 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03413540 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03214224 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT03509064 — Predictive Biomarker (PRD): 14-3-3 protein sigma
Genes: SFN; HME1
Study NCT03178149 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04152135 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04274933 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04274933 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04274933 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04274933 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04274933 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT01862978 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study NCT01862978 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03948763 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT01477346 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT03726372 — Pharmacodynamic Biomarker (PDY): Transmembrane glycoprotein NMB
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study NCT04256772 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT03559972 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TNS1 mRNA
Genes: TNS1; TNS
Study NCT00529373 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT04201457 — Predictive Biomarker (PRD): NF1 mRNA
Genes: NF1
Study NCT02287181 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03268083 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT00247702 — Predictive Biomarker (PRD): VKORC1 mRNA
Genes: VKORC1; VKOR; MSTP134; MSTP576; UNQ308/PRO351
Study NCT00247702 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT03857646 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study NCT00087477 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study NCT00162552 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT00956501 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT04444024 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study NCT04444024 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01530659 — Predictive Biomarker (PRD): CNTF mRNA
Genes: CNTF
Study NCT04057742 — Monitoring Biomarker (MOI): Cell-free DNA
Study NCT00459563 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00118157 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT00118157 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00118157 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT03627975 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study NCT01874353 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT01874353 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study NCT00372177 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT04073537 — Predictive Biomarker (PRD): FLT1 mRNA
Genes: FLT1; FLT; FRT; VEGFR1
Study NCT04073537 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study NCT01712620 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT01673295 — Surrogate Endpoint (SUR): Complete renal response
Study NCT02021981 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03307252 — Safety Biomarker (SAF): SLCO1B1
Genes: OATP-C; LST-1; OATP1B1
Study NCT03307252 — Predictive Biomarker (PRD): SLC22A2 mRNA
Genes: SLC22A2; OCT2
Study NCT04038905 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT04166786 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT03859167 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01692626 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03835923 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00455403 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00455403 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT00110396 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT00014430 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05669404 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03466450 — Predictive Biomarker (PRD): SHH mRNA
Genes: SHH
Study NCT02696343 — Predictive Biomarker (PRD): GLS2 mRNA
Genes: GLS2; GA
Study NCT03129724 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT03684109 — Pharmacodynamic Biomarker (PDY): 2-hydroxyglutarate
Study NCT00011648 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02389309 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study NCT02389309 — Predictive Biomarker (PRD): SRC mRNA
Genes: SRC; SRC1
Study NCT01491763 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT04460911 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04460911 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04460911 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04460911 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02570789 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00184886 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT00184886 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT03788850 — Surrogate Endpoint (SUR): Cervical intraepithelial neoplasia
Study NCT05570240 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT02641327 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03103438 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT02471729 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04298944 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00968747 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT00450879 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00450879 — Predictive Biomarker (PRD): VEGF
Genes: VEGFA; VEGF-A; VPF
Study NCT00450879 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT03903289 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT01377948 — Predictive Biomarker (PRD): AGER mRNA
Genes: AGER; RAGE
Study NCT00688350 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03105180 — Pharmacodynamic Biomarker (PDY): Blood coagulation
Study NCT00494637 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT02687568 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01579773 — Predictive Biomarker (PRD): ENG mRNA
Genes: ENG; END
Study NCT02277587 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT03139474 — Predictive Biomarker (PRD): Hormone receptor
Study NCT00856492 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT01938638 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT01129557 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03596957 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT02242812 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01244438 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study NCT00151931 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study NCT01296776 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT02504918 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT02504918 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT03211676 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT02847260 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT02847260 — Surrogate Endpoint (SUR): Pulmonary vascular resistance
Study NCT01219816 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study NCT03383965 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study NCT02716961 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study NCT03631706 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT03631706 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT03631706 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT02198170 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT03691701 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02942017 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study NCT00350207 — Predictive Biomarker (PRD): ADRB2 mRNA
Genes: ADRB2; ADRB2R; B2AR
Study NCT00350207 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT02772133 — Predictive Biomarker (PRD): PRCP mRNA
Genes: PRCP; PCP
Study NCT03473444 — Surrogate Endpoint (SUR): Serum uric acid
Study NCT02604342 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT02129231 — Predictive Biomarker (PRD): LPO mRNA
Genes: LPO; SAPX
Study NCT03981835 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT01611727 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study NCT02598635 — Predictive Biomarker (PRD): TNFRSF11B mRNA
Genes: TNFRSF11B; OCIF; OPG
Study NCT02598635 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Osteopontin
Genes: SPP1; BNSP; OPN; PSEC0156
Study NCT02881398 — Surrogate Endpoint (SUR): Blood pressure
Study NCT01723800 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04166838 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT01161069 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03312244 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT00811733 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06438614 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT00273520 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT01904695 — Surrogate Endpoint (SUR): Blood pressure
Study NCT00518271 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT01139775 — Predictive Biomarker (PRD): CHEK1 mRNA
Genes: CHEK1; CHK1
Study NCT00039559 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT01622257 — Surrogate Endpoint (SUR): Serum testosterone
Study NCT02681861 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT00155064 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT02352571 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04608487 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT03514524 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT03514524 — Predictive Biomarker (PRD): SV2A mRNA
Genes: SV2A; KIAA0736; PSEC0174
Study NCT01071642 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT03926117 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT04237376 — Monitoring Biomarker (MOI): HBV DNA
Study NCT04237376 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT06795841 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06795841 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT06795841 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06795841 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT02670226 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT02840474 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT02473627 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study NCT02473627 — Predictive Biomarker (PRD): CYP2C9 mRNA
Genes: CYP2C9; CYP2C10
Study NCT02473627 — Safety Biomarker (SAF): Cytochrome P450 2C19
Genes: CYP2C19
Study NCT02473627 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study NCT00004495 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT03548818 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT01936844 — Safety Biomarker (SAF): Interleukin 1
Study NCT01936844 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT03657875 — Surrogate Endpoint (SUR): Serum potassium
Study NCT01486446 — Predictive Biomarker (PRD): DNA repair endonuclease XPF
Genes: ERCC4; ERCC11; XPF
Study NCT03023215 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02869243 — Predictive Biomarker (PRD): BMP4 mRNA
Genes: BMP4; BMP2B; DVR4
Study NCT04526028 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04526028 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04526028 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT00134680 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02613793 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05576168 — Predictive Biomarker (PRD): RBP4 mRNA
Genes: RBP4; PRO2222
Study NCT02935790 — Predictive Biomarker (PRD): HDAC6 mRNA
Genes: HDAC6; KIAA0901; JM21
Study NCT04666064 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT00278057 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04409145 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT03977896 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT03938883 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT03519412 — Predictive Biomarker (PRD): O-6-methylguanine-DNA-alkyltransferase
Genes: MGMT
Study NCT03519412 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study NCT02041819 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT02041819 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT00570154 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT03228979 — Surrogate Endpoint (SUR): Blood pressure
Study NCT02481089 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study NCT01702519 — Predictive Biomarker (PRD): NTS mRNA
Genes: NTS
Study NCT02123004 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT01372618 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02778685 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT02127151 — Predictive Biomarker (PRD): Phosphatase and tensin homolog
Genes: PTEN; MMAC1; TEP1
Study NCT02127151 — Predictive Biomarker (PRD): Microsatellite instability
Study NCT04762160 — Predictive Biomarker (PRD): EZH2 mRNA
Genes: EZH2; KMT6
Study NCT00271349 — Safety Biomarker (SAF): Th2 cell
Study NCT00594672 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT01734005 — Surrogate Endpoint (SUR): Blood pressure